Empson M, Flood V, Ma G, Eastman C J, Mitchell P
Immunology Department, Auckland City Hospital, Auckland, New Zealand.
Intern Med J. 2007 Jul;37(7):448-55. doi: 10.1111/j.1445-5994.2007.01367.x.
To determine the prevalence of thyroid disease in an older Australian population in a population-based cross-sectional study.
Community-living subjects, aged 49 years or older, in two Blue Mountains postcodes were invited to participate in an eye, nutrition and health study between 1997 and 2000.
Three thousand five hundred and nine of the 4489 identified persons participated. Fifty-seven per cent of 3504 who completed questionnaires were women; their mean age was 66.8 years. Thyroid-stimulating hormone (TSH) was measured in 2665 subjects (76% of those completing the questionnaire). The main outcome measures were serum TSH and free thyroxine levels, serum lipids, urate and sugar levels and questionnaire responses.
The prevalence of recognized thyroid disease (either self-reported history of thyroid disease or current thyroxine treatment) was 10% (95% confidence interval (CI) 8.9-11.1%). An additional 3.6% (95%CI 2.9-4.3%) of participants had unrecognized thyroid disease (abnormal TSH). The TSH was abnormal in 7.1% (95%CI 5.8-8.4%) of women and 3.7% (95%CI 2.6-4.8%) of men. Sixty-five per cent of those with an abnormal TSH did not report a history of thyroid disease, whereas 25% of those taking thyroxine replacement therapy had an abnormal TSH level. The prevalence of hypothyroidism increased with increasing age in women. The mean fasting cholesterol was 0.36 mmol/L (95%CI 0.15-0.57) higher in hypothyroid subjects than in euthyroid subjects.
Thyroid disease in older Australian women is relatively common and may be undiagnosed. Ongoing monitoring of patients on thyroxine replacement therapy is important, given that 25% of treated patients had an abnormal TSH.
在一项基于人群的横断面研究中确定澳大利亚老年人群中甲状腺疾病的患病率。
1997年至2000年期间,邀请了蓝山地区两个邮政编码区域内年龄在49岁及以上的社区居住者参与一项眼部、营养与健康研究。
4489名被识别出的人员中有3509人参与。在完成问卷的3504人中,57%为女性;她们的平均年龄为66.8岁。对2665名受试者(占完成问卷者的76%)进行了促甲状腺激素(TSH)检测。主要观察指标为血清TSH和游离甲状腺素水平、血脂、尿酸和血糖水平以及问卷回答情况。
已确诊的甲状腺疾病(无论是自我报告的甲状腺疾病史还是当前正在接受甲状腺素治疗)的患病率为10%(95%置信区间(CI)8.9 - 11.1%)。另外3.6%(95%CI 2.9 - 4.3%)的参与者患有未被识别的甲状腺疾病(TSH异常)。女性中TSH异常的比例为7.1%(95%CI 5.8 - 8.4%),男性为3.7%(95%CI 2.6 - 4.8%)。TSH异常者中有65%未报告甲状腺疾病史,而接受甲状腺素替代治疗者中有25%的TSH水平异常。女性甲状腺功能减退的患病率随年龄增长而升高。甲状腺功能减退受试者的平均空腹胆固醇比甲状腺功能正常者高0.36 mmol/L(95%CI 0.15 - 0.57)。
澳大利亚老年女性中的甲状腺疾病相对常见且可能未被诊断出来。鉴于25%接受治疗的患者TSH异常,对接受甲状腺素替代治疗的患者进行持续监测很重要。